Introduction

Wound healing is one of the most complex biological processes in the human body, involving a coordinated cascade of inflammation, cell proliferation, and tissue remodeling. At the molecular level, peptide-based growth factors orchestrate much of this process -- signaling cells to migrate, proliferate, and rebuild damaged tissue. Understanding how these peptides function has opened new avenues in clinical wound care, from diabetic ulcer management to advanced regenerative medicine.

The Biology of Wound Healing

Normal wound healing proceeds through four overlapping phases:

Hemostasis: Platelet aggregation and clot formation
Inflammation: Immune cells clear debris and pathogens
Proliferation: New tissue formation, including angiogenesis (new blood vessel growth), granulation tissue, and re-epithelialization
Remodeling: Collagen reorganization and scar maturation

Peptide growth factors play critical roles in each phase, serving as molecular signals that coordinate cellular behavior throughout the healing process.

Key Peptide Growth Factors in Wound Repair

Epidermal Growth Factor (EGF)

EGF is a 53-amino-acid peptide that promotes cell proliferation and migration, accelerating the re-epithelialization phase of wound healing. Research indicates that EGF stimulates keratinocyte and fibroblast activity, encouraging the formation of new skin tissue over wound beds.

A systematic review and meta-analysis published in Burns & Trauma evaluated the clinical effectiveness of EGF in acute skin wound healing. The analysis found evidence supporting EGF's role in accelerating wound closure, particularly in surgical and burn wounds.

Fibroblast Growth Factor (FGF)

The FGF family includes over 20 members, several of which play direct roles in wound repair. FGF enhances angiogenesis and granulation tissue formation -- two processes essential for supplying nutrients and oxygen to healing tissue. FGF-2 (basic FGF) has been particularly well-studied for its ability to promote neovascularization in wound beds.

A 2024 review examined FGF-derived peptides and their therapeutic potential, noting that peptide fragments derived from FGF proteins can retain biological activity while offering improved stability and delivery characteristics. The FGF7-derived peptide KGFp, when used in combination with stem cells, has shown the ability to significantly increase wound closure rates in diabetic mouse models while enhancing skin tissue integrity.

Platelet-Derived Growth Factor (PDGF)

PDGF is released from platelet alpha-granules during clot formation and serves as one of the earliest signals in wound healing. It attracts cells to the wound site through chemotaxis and stimulates cell growth and division. PDGF also enhances extracellular matrix remodeling and promotes angiogenesis.

PDGF represents the only growth factor to have achieved FDA approval in a wound healing indication. Becaplermin gel (Regranex), a recombinant human PDGF-BB formulation, was approved by the FDA for the treatment of deep neuropathic diabetic foot ulcers. Clinical trials demonstrated accelerated healing through increased granulation tissue formation and epithelialization.

Platelet-Rich Plasma: A Natural Peptide Cocktail

Platelet-rich plasma (PRP) therapy leverages the body's own growth factor peptides for wound healing. PRP is prepared by concentrating platelets from the patient's own blood, resulting in elevated levels of PDGF, transforming growth factor-beta (TGF-beta), vascular endothelial growth factor (VEGF), and other bioactive peptides.

Research describes platelet-derived peptides as key mediators of regeneration, noting their roles in angiogenesis, extracellular matrix remodeling, and stem cell recruitment. PRP has found clinical applications in chronic wound management, orthopedic surgery, and dermatologic procedures.

Clinical Applications in Wound Care

Peptide-based wound healing strategies are currently applied across several clinical settings:

Diabetic foot ulcers: Becaplermin (PDGF-BB) gel remains the standard growth-factor-based treatment, with over 122 peer-reviewed publications documenting its clinical use
Burn wounds: EGF-containing formulations have demonstrated accelerated re-epithelialization in clinical studies
Chronic wounds: PRP therapy offers an autologous approach to delivering multiple growth factor peptides simultaneously
Surgical wounds: Collagen-mimetic peptides are being investigated as scaffolds that can integrate growth factor delivery with structural wound support

Emerging Research Directions

The field continues to advance with several promising developments:

Bioactive peptide discovery: Researchers are identifying novel wound-healing peptides from natural sources, including antimicrobial peptides that combine infection control with tissue repair signaling
Peptide-loaded biomaterials: Integration of growth factor peptides into collagen scaffolds, hydrogels, and nanofiber dressings for sustained, localized delivery
Synthetic peptide mimetics: Shorter peptide fragments that replicate the active domains of full-length growth factors, potentially offering improved stability and manufacturing advantages

Conclusion

Peptide-based growth factors are fundamental to the wound healing process, and translating this understanding into clinical applications has already produced FDA-approved therapies. From EGF and FGF to PDGF and platelet-derived peptide cocktails, these molecules represent a growing toolkit for clinicians managing both acute and chronic wounds. As delivery technologies and peptide engineering continue to advance, the role of peptides in wound care is likely to expand further.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for wound care management.

The Role of Peptides in Wound Healing